Biodexa Pharmaceuticals Stock (NASDAQ: BDRX) stock price, news, charts, stock research, profile.
Open | $0.39 |
Close | $0.37 |
Volume / Avg. | 146.54K / 1.46M |
Day Range | $0.37 - $0.39 |
52 Wk Range | 0.35 - 8.81 |
Market Cap | $5.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 0.59% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.
Other companies in Biodexa Pharmaceuticals’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Coeptis Therapeutics (NASDAQ:COEP) and Palisade Bio (NASDAQ:PALI).
Biodexa Pharmaceuticals has a consensus price target of $8.00.
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $0.3855 last updated September 18, 2024 at 4:22 PM EDT.
There are no upcoming dividends for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals’s H1 earnings are confirmed for Tuesday, October 1, 2024.
There is no upcoming split for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.